Cargando…
Lung Cancer Surgery after Neoadjuvant Immunotherapy
SIMPLE SUMMARY: Neoadjuvant immunotherapy is a novel approach for lung cancer patients in stages where curative intent treatment is possible. The rationale is a based on the idea that recognition by the immune system is activated by the entire tumor prior to surgical resection. Promising pathologic...
Autores principales: | Stefani, Dirk, Plönes, Till, Viehof, Jan, Darwiche, Kaid, Stuschke, Martin, Schuler, Martin, Aigner, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393473/ https://www.ncbi.nlm.nih.gov/pubmed/34439187 http://dx.doi.org/10.3390/cancers13164033 |
Ejemplares similares
-
The nodule in the emphysematous lung: an appeal for surgery in a lung volume reduction concept
por: Plönes, Till, et al.
Publicado: (2023) -
Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer
por: Hockmann, Jan, et al.
Publicado: (2023) -
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
por: Guberina, Nika, et al.
Publicado: (2022) -
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [(18)F]FDG PET/CT compared to the histopathology reference standard
por: Hautzel, Hubertus, et al.
Publicado: (2021) -
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
por: Guberina, Maja, et al.
Publicado: (2021)